Stanford Health Care, an academic health system, is teaming with GE Ventures, a Menlo Park, Calif.-based capital investment firm, to launch Evidation Health, an evidence-based digital medicine company.
The company will be separate from Stanford Health Care and GE Ventures. It will aim to validate digital health products such as wearables and mobile health monitoring devices by generating real-world clinical and economic evidence. It will combine outcomes data and predictive analytics to help companies and healthcare organizations deploy the most effective digital medicine tools.
“As an early adopter of electronic health records, virtual visits and precision health, Stanford Health Care is excited to join with GE Ventures to launch Evidation Health to provide real-world assessment and validation of digital health care technologies."
The new company, which will join with The Activity Exchange, a digital health company with strong predictive analytics capabilities, pegged Deborah Kilpatrick as the CEO. It closed Series A financing in January of this year, led by GE Ventures with participation from Asset Management Ventures and Rock Health.
